Your session is about to expire
← Back to Search
Study Summary
This trial seeks to find out if noticing instances of forgetting leads to a decline in memory performance.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research endeavor accommodate participants who are of legal age?
"The minimum age for enrolment in this medical study is 65, whereas the maximum age of participants must not exceed 80 years old."
What are the key goals of this clinical experiment?
"The primary outcome of this trial, which will be monitored over approximately 3 minutes is the Everyday Memory Questionnaire-Revised (EMQ-R; Royle & Lincoln, 2008). Secondary objectives include Subjective Age Measure (Barak & Schiffman, 1981) - an evaluation of cognitive, psychological, biological and social domains to ascertain how old participants feel they are compared to their actual age - Image of Aging Scale (Levy, Kasl, & Gill, 2004), a comparison between positive and negative stereotypes about aging across nine dimensions such as activity levels or physical health. Finally we have Langer Mindfulness Scale (LMS-14"
Who is eligible to participate in this research project?
"This medical trial has a target enrollment of 210 seniors aged 65-80, who are experiencing memory difficulties and own smartphones. Furthermore, applicants must indicate that they have worries about their cognitive performance when asked to do so."
Are there still opportunities for participants to join this clinical trial?
"The information hosted on clinicaltrials.gov demonstrates that this medical trial is not presently enrolling candidates. It was first posted on August 30th 2018 and its most recent update occurred October 25th 2021. Nonetheless, there are alternate trials currently admitting participants."
Share this study with friends
Copy Link
Messenger